The Disruptive Technologies Innovation Fund (DTIF) is a €500 million fund established under Project Ireland 2040. The successful projects will receive over €75 million in funding from 2019 to 2021. The projects can use the funding to develop and deploy their disruptive innovative technologies on a commercial basis. The fund is one of the first of its type in the world and is aimed at tackling national and global challenges to secure the jobs of the future. You can learn more about the Disruptive Technologies Innovation Fund here and the successful projects here.

CAPPA was successful in receiving funding in the first round of the DTIF for their project with Hooke Bio, a start-up pharmaceutical company. Applications involved a high degree of collaboration, with many bids for funding involving multiple partners. CAPPA was one of the 27 successful projects to receive funding through the highly competitive process involving screening by a panel of international experts.

As a result of the large quantity of applications for the first round of funding as well as the high level of quality of these applications the DTIF have opened a phase two call. There will be an information session on the 5th of July in the University of Limerick organised by Enterprise Ireland where you can learn more. As well as practical information about the second round of the fund, the event will showcase some of the innovations developed in Ireland under the first round. If you are interested in attending this event or would like to learn more about the DTIF you can contact us for additional information here.